Assignee
CEPHALON INC
US·186 granted patents·65 pending applications·4,554 citations·filing 1989–2021
Top patents by PatentIndex Score
251 records- 0197US8344006B2Liquid formulations of bendamustineCEPHALON INC·Filed 2012·Granted Jan 1, 2013·51 cites·10 claims
- 0297US6630500B2Selected fused pyrrolocarbazolesCEPHALON INC·Filed 2001·Granted Oct 7, 2003·162 cites·37 claims
- 0396US5648335APrevention and treatment of peripheral neuropathyCEPHALON INC·Filed 1996·Granted Jul 15, 1997·155 cites·3 claims
- 0496US5591855AFused pyrrolocarbazolesCEPHALON INC·Filed 1995·Granted Jan 7, 1997·115 cites·16 claims
- 0596US5498616ACysteine protease and serine protease inhibitorsCEPHALON INC·Filed 1994·Granted Mar 12, 1996·79 cites·18 claims
- 0696US5475110AFused PyrrolocarbazolesCEPHALON INC·Filed 1994·Granted Dec 12, 1995·93 cites·18 claims
- 0796US5093317ATreating disorders by application of insulin-like growth factorCEPHALON INC·Filed 1989·Granted Mar 3, 1992·212 cites·4 claims
- 0895US10138296B2Antibodies that specifically bind to TL1ACEPHALON INC·Filed 2016·Granted Nov 27, 2018·17 cites·34 claims
- 0995US8791270B2Bendamustine pharmaceutical compositionsCEPHALON INC·Filed 2013·Granted Jul 29, 2014·31 cites·23 claims
- 1095US6399780B1Isomeric fused pyrrolocarbazoles and isoindolonesCEPHALON INC·Filed 2000·Granted Jun 4, 2002·61 cites·19 claims
- 1195US6346548B1Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigueCEPHALON INC·Filed 2000·Granted Feb 12, 2002·89 cites·12 claims
- 1294US7276246B2Dissolvable backing layer for use with a transmucosal delivery deviceCEPHALON INC·Filed 2004·Granted Oct 2, 2007·60 cites·25 claims
- 1394US5869336ARecombinant enzymatically active calpain expressed in a baculovirus systemCEPHALON INC·Filed 1997·Granted Feb 9, 1999·168 cites·9 claims
- 1494US5569648APrevention and treatment of peripheral neuropathyCEPHALON INC·Filed 1994·Granted Oct 29, 1996·103 cites·5 claims
- 1593US11220549B2Antibodies that specifically bind to TL1A and methods of treating respiratory tract diseasesCEPHALON INC·Filed 2018·Granted Jan 11, 2022·8 cites·31 claims
- 1693US8669279B2Solid forms of bendamustine hydrochlorideCEPHALON INC·Filed 2013·Granted Mar 11, 2014·17 cites·22 claims
- 1793US8609863B2Bendamustine pharmaceutical compositionsCEPHALON INC·Filed 2012·Granted Dec 17, 2013·21 cites·4 claims
- 1893US7306812B2Dissolvable backing layer for use with a transmucosal delivery deviceCEPHALON INC·Filed 2004·Granted Dec 11, 2007·46 cites·60 claims
- 1993US7074793B2Cyclic substituted fused pyrrolocarbazoles and isoindolonesCEPHALON INC·Filed 2004·Granted Jul 11, 2006·60 cites·25 claims
- 2093US6455525B1Heterocyclic substituted pyrazolonesCEPHALON INC·Filed 2000·Granted Sep 24, 2002·63 cites·20 claims
- 2192US8883836B2Solid forms of bendamustine hydrochlorideCEPHALON INC·Filed 2014·Granted Nov 11, 2014·12 cites·22 claims
- 2292US7601716B2Pyridopyrazines and derivatives thereof as ALK and c-Met inhibitorsCEPHALON INC·Filed 2007·Granted Oct 13, 2009·23 cites·19 claims
- 2392US6488164B2Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigueCEPHALON INC·Filed 2001·Granted Dec 3, 2002·45 cites·12 claims
- 2492US6455588B1Compositions including modafinil for treatment of eating disorders and for appetite stimulationCEPHALON INC·Filed 2000·Granted Sep 24, 2002·52 cites·30 claims
- 2592US6359130B1Bridged indenopyrrolocarbazolesCEPHALON INC·Filed 2000·Granted Mar 19, 2002·48 cites·14 claims
- 2692US6310057B1α-ketoamide multicatalytic protease inhibitorsCEPHALON INC·Filed 2000·Granted Oct 30, 2001·31 cites·32 claims
- 2792US5550262AMulticatalytic protease inhibitorsCEPHALON INC·Filed 1994·Granted Aug 27, 1996·52 cites·10 claims
- 2891US8895756B2Bendamustine pharmaceutical compositionsCEPHALON INC·Filed 2012·Granted Nov 25, 2014·13 cites·4 claims
- 2991US6875893B2Preparations of a sulfinyl acetamideCEPHALON INC·Filed 2003·Granted Apr 5, 2005·28 cites·27 claims
- 3091US6492396B2Substituted thioacetamidesCEPHALON INC·Filed 2001·Granted Dec 10, 2002·47 cites·24 claims
- 3191US5633228APrevention and treatment of peripheral neuropathyCEPHALON INC·Filed 1994·Granted May 27, 1997·73 cites·3 claims
- 3291US5594009AFused pyrrolocarbazolesCEPHALON INC·Filed 1995·Granted Jan 14, 1997·63 cites·27 claims
- 3390US9902696B21,4-substituted piperidine derivativesCEPHALON INC·Filed 2016·Granted Feb 27, 2018·7 cites·21 claims
- 3490US5705511AFused pyrrolocarbazolesCEPHALON INC·Filed 1995·Granted Jan 6, 1998·100 cites·69 claims
- 3589US6670358B2Substituted thioacetamidesCEPHALON INC·Filed 2001·Granted Dec 30, 2003·32 cites·29 claims
- 3689US6548062B2Method of treating cancer with anti-neurotrophin agentsCEPHALON INC·Filed 2001·Granted Apr 15, 2003·89 cites·15 claims
- 3789US5461146ASelected protein kinase inhibitors for the treatment of neurological disordersCEPHALON INC·Filed 1993·Granted Oct 24, 1995·71 cites·4 claims
- 3888US7576206B2Proteasome inhibitors and methods of using the sameCEPHALON INC·Filed 2004·Granted Aug 18, 2009·23 cites·1 claims
- 3988US7446122B2Substituted indole derivativesCEPHALON INC·Filed 2004·Granted Nov 4, 2008·29 cites·37 claims
- 4088US6919378B2Pharmaceutical solutions of modafinil compoundsCEPHALON INC·Filed 2002·Granted Jul 19, 2005·39 cites·31 claims
- 4188US6489363B2Pharmaceutical solutions of modafinil compoundsCEPHALON INC·Filed 2001·Granted Dec 3, 2002·36 cites·39 claims
- 4287US9533955B2Solid forms of bendamustine hydrochlorideCEPHALON INC·Filed 2016·Granted Jan 3, 2017·4 cites·12 claims
- 4387US9339502B2Fused bicyclic 2,4-diaminopyrimidine derivative as a dual ALK and FAK inhibitorCEPHALON INC·Filed 2015·Granted May 17, 2016·5 cites·21 claims
- 4487US9132128B2Fused bicyclic 2,4-diaminopyrimidine derivative as a dual ALK and FAK inhibitorCEPHALON INC·Filed 2014·Granted Sep 15, 2015·7 cites·20 claims
- 4587US7919502B2Pyridopyrazines and derivatives thereof as ALK and c-MET inhibitorsCEPHALON INC·Filed 2009·Granted Apr 5, 2011·9 cites·8 claims
- 4687US6919367B2Substituted thioacetamidesCEPHALON INC·Filed 2003·Granted Jul 19, 2005·24 cites·35 claims
- 4787US6500802B1Peptidyl-2-amino-1-hydroxyalkanesulfonic acid cysteine protease inhibitorsCEPHALON INC·Filed 2000·Granted Dec 31, 2002·28 cites·30 claims
- 4887US6288231B1Peptide-containing α-ketoamide cysteine and serine protease inhibitorsCEPHALON INC·Filed 2000·Granted Sep 11, 2001·19 cites·5 claims
- 4986US9623026B2Fused bicyclic 2,4-diaminopyrimidine derivative as a dual ALK and FAK inhibitorCEPHALON INC·Filed 2016·Granted Apr 18, 2017·4 cites·10 claims
- 5086US5990083AMulticatalytic protease inhibitorsCEPHALON INC·Filed 1997·Granted Nov 23, 1999·50 cites·11 claims
Showing the top 50 of 251 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →